Viersener Straße 450
41063 Mönchengladbach
Phone:
02161-892-0
Fax:
02161-892-1003
Mail:
ed.flihairam@ofni
Quantity performed | 151 |
Exception? | No exception |
Quantity performed | 17 |
Exception? | No exception |
Quantity performed | 12 |
Exception? | No exception |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 151 |
Quantity forecast year: | 164 |
Examination by state associations? | yes |
Exemption? | yes |
Result of the examination by the federal state authorities? | yes |
Transitional arrangement? | no |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 17 |
Quantity forecast year: | 24 |
Examination by state associations? | yes |
Exemption? | yes |
Result of the examination by the federal state authorities? | yes |
Transitional arrangement? | no |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 12 |
Quantity forecast year: | 9 |
Examination by state associations? | yes |
Exemption? | yes |
Result of the examination by the federal state authorities? | yes |
Transitional arrangement? | no |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 76 |
Quantity forecast year: | 77 |
Examination by state associations? | yes |
Exemption? | yes |
Result of the examination by the federal state authorities? | yes |
Transitional arrangement? | no |
No. | Explanation |
---|---|
CQ01 | Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm |
CQ03 | Quality assurance measures for the implementation of positron emission tomography (PET) in hospitals for the indications non-small-cell lung cancer (NSCLC) and solid pulmonary nodules |
CQ25 | Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V |
CQ30 | Quality assurance guideline for interstitial LDR brachytherapy for low-risk localized prostate cancer (effective January 8, 2021). |
CQ27 | Guideline on quality assurance measures for inpatient care with bronchoscopic lung volume reduction procedures for severe emphysema (QS Guideline bronchoscopic LVR /QS-RL BLVR) |
Number | Group |
---|---|
205 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
133 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
52 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.
Information gathering on the topic
Age-appropriate complaint options
Special requirements for the selection of persons
Training of employees on AMTS related topics
Availability of appropriate, topic-specific informational materials for patients on AMTS e.g. for chronic diseases, for high-risk drugs, for children
Verfahrensanweisung "Patientendokumentation"
31.01.2019
Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)
QM-Handbuch Pflege- und Funktionsdienst: Teil B1 "Medikamentenversorgung" (Stand 01.06.2015); Dienstanweisung zum Umgang mit Medikamentenanordnungen (Stand 17.01.2014); Verfahrensanweisung "Patientendokumentation"
31.01.2019
Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)
Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)
FL01 - Lectureships / teaching posts at colleges and universities
FL03 - Student training (clinical traineeship / internship year)
FL04 - Project-related cooperation with colleges and universities
FL05 - Participation in multi-centre Phase I/II studies
FL06 - Participation in multi-centre phase III/IV studies
FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies
FL08 - Editors of scientific journals/textbooks
FL09 - Doctoral supervision
HB01 - Nurse and health care worker (m/f)
HB03 - Physical therapist / physiotherapist (m/f)
HB05 - Medical technical radiology assistant (MTRA) (m/f)
HB07 - Surgical technical assistant (m/f)
HB15 - Anaesthesia technical assistant (m/f)
HB19 - Nursing professionals
HB20 - Nursing professional B. Sc.
HB21 - Geriatric nurse (m/f)
Frau Sabine Groth
Patientenfürsprecherin
Viersener Straße 450
41063 Mönchengladbach
Phone:
02161
-892-3500
Mail:
ed.flihairam@rehcerpsreufnetneitap
Frau Claudia Lehnen
Patientenfürsprecherin
Viersener Straße 450
41063 Mönchengladbach
Phone:
02161
-892-3500
Mail:
ed.flihairam@rehcerpsreufnetneitap
Frau Sabine Groth
Patientenfürsprecherin
Viersener Straße 450
41063 Mönchengladbach
Phone:
02161
-892-3500
Mail:
ed.flihairam@rehcerpsreufnetneitap
Frau Claudia Lehnen
Patientenfürsprecherin
Viersener Straße 450
41063 Mönchengladbach
Phone:
02161
-892-3500
Mail:
ed.flihairam@rehcerpsreufnetneitap
Dr. Paul Schneider
Geschäftsführer
Viersener Straße 450
41063 Mönchengladbach
Phone:
02161
-892-1001
Mail:
ed.flihairam@tnemeganamedrewhcseb
Frau Susanne Ropertz
Geschäftsbereichsleitung Betriebsorganisation und Qualitätsmanagement
Viersener Straße 450
41063 Mönchengladbach
Phone:
02161
-892-5500
Mail:
ed.flihairam@ztrepoR.ennasuS
Prof. Dr. med. Ullrich Graeven
Chefarzt
Viersener Straße 450
41063 Mönchengladbach
Phone:
02161
-892-2201
Mail:
ed.flihairam@1erenni
Prof. Dr. med. Herbert Sperling
Ärztlicher Direktor
Viersener Straße 450
41063 Mönchengladbach
Phone:
02161
-892-2301
Mail:
ed.flihairam@gnilreps.trebreh
Heike Hundertmark
Assistentin der Geschäftsführung
Viersener Straße 450
41063 Mönchengladbach
Phone:
02161
-892-1001
Mail:
ed.flihairam@kramtrednuh.ekieh
Phone:
02161-892-0
Fax:
02161-892-1003
Mail:
ed.flihairam@ofni
Birgit Gillmann
Pflegedirektorin
Viersener Straße 450
41063 Mönchengladbach
Phone:
02161
-892-1196
Mail:
ed.flihairam@nnamllig.tigrib
Dr. Paul Schneider
Geschäftsführer
Viersener Straße 450
41063 Mönchengladbach
Phone:
02161
-892-1001
Mail:
ed.flihairam@fg
Dr. Paul Schneider
Geschäftsführer
Viersener Straße 450
41063 Mönchengladbach
Phone:
02161
-892-1001
Mail:
ed.flihairam@fg
Prof. Dr. med. Herbert Sperling
Ärztlicher Direktor
Viersener Straße 450
41063 Mönchengladbach
Phone:
02161
-892-2301
Mail:
ed.flihairam@gnilrepS.trebreH
IK: 260510666
Location number: 771555000
Old location number: 771555000